GEODE CAPITAL MANAGEMENT, LLC

Position in OCS — Oculis Holding AG

CIK 1214717 BOSTON, MA

Position in OCS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,566,815

+$846,677 QoQ

Shares Held

58,925

+63.4% QoQ

Ownership

0.098%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. OCS ranks #290 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,566,815	58,925	+63.4%	Shares	Defined	2026-05-15
2025-12-31	$720,138	36,061	+22.5%	Shares	Defined	2026-02-09
2025-09-30	$517,484	29,436	0.0%	Shares	Defined	2025-11-12
2025-06-30	$571,352	29,436	+27.7%	Shares	Defined	2025-08-08
2025-03-31	$438,679	23,052	+37.7%	Shares	Defined	2025-05-13
2024-12-31	$284,648	16,744	+12.0%	Shares	Defined	2025-02-12
2024-09-30	$183,213	14,944	0.0%	Shares	Defined	2024-11-12
2024-06-30	$178,580	14,944	0.0%	Shares	Defined	2024-08-09
2024-03-31	$180,075	14,944	—	Shares	Defined	2024-05-13
No filing history on record for this holder in this stock.